Royal Philips Electronics and Corindus Vascular Robotics announced a distribution agreement for Corindus’ CorPath 200 System. The system was recently cleared by the (FDA) and is the world’s first robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries in patients with Coronary Artery Disease (CAD). The financial details of the exclusive distribution agreement were not disclosed. Corindus, founded in 2002 by Prof. Rafael Beyar, the director general of Rambam Medical Center in Haifa, currently operates in Massachusetts.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments